IART
Integra Lifesciences Holdings·NASDAQ
--
--(--)
--
--(--)
4.74 / 10
Netural
Capital flow shows a good score of 7.63/10, with Extra-large inflows positive even as other scales trend negative. However, analyst sentiment is mixed but skewed bearish—Neutral (50%), Sell (25%), Strong Sell (25%)—based on four recent evaluations, aligning with the cautious outlook.
Fund Flow Rating
Analyst RatingSell
Wall Street Opinions
Sell
Strong Buy
0%
Buy
0%
Hold
0%
Sell
25%
Strong Sell
25%
Date2025-10-31
InstitutionCitigroup
Times predicted2
Historical Win Rate50.0%
What is the analyst consensus for IART?
- IART holds a Bearish analyst rating, with 25% of experts assigning a Sell grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.74/10 (Netural).
